We are live on ! Find out more
VNRX icon

VolitionRx Ltd

36 hedge funds and large institutions have $15M invested in VolitionRx Ltd in 2019 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

16% more funds holding

Funds holding: 3136 (+5)

0.01% more ownership

Funds ownership: 0.38%0.39% (+0.01%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

14% less capital invested

Capital invested by funds: $17.5M → $15M (-$2.44M)

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

Holders
36
Holders Change
+5
Holders Change %
+16.13%
% of All Funds
0.71%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
6
Reduced
8
Closed
3
Calls
Puts
Net Calls
Net Calls Change

VNRX Hedge Fund Activity: Q4 2019 in Review

36 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q4 2019, worth a combined $15M — down 14% from $17.5M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new VNRX positions and 3 closed out — a net gain of 5 holders — while 6 added to existing stakes and 8 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $279K. The largest seller was JP Morgan Chase, cutting an estimated $124K.

  • 36 institutional investors held VolitionRx Ltd (VNRX) as of Q4 2019, up from 31 in Q3 2019.
  • Funds reported $15M of VolitionRx Ltd stock for Q4 2019, down 14% quarter-over-quarter.
  • 8 funds opened new VolitionRx Ltd positions in Q4 2019 and 3 closed out, a net change of +5 holders.
  • The largest VolitionRx Ltd buyer in Q4 2019 was Morgan Stanley, an estimated $279K added.
  • The largest VolitionRx Ltd seller in Q4 2019 was JP Morgan Chase, an estimated $124K sold.

Based on aggregated 13F filings for Q4 2019.